Advertisement · 728 × 90

Posts by Jason Westin MD MS FACP

Post image

Important poster: ALPHA3, the first clinical trial enrolling patients with LBCL who have complete response by PET/CT after 1L therapy but have +ctDNA. Trial in Progress poster tonight at #ASH24 #lymsm

1 year ago 13 2 1 0
Post image

Come join us to learn about moving CAR T-cell therapy forward in patients with lymphoma. Ongoing now at the convention center at #ASH24 @ash-hematology.bsky.social #lymsm #MedSky #OncSky

1 year ago 22 0 0 0

#HCWvsHunger Houston roll call!

@ibcradiation.bsky.social
@cdfuller.bsky.social
@fischmd.bsky.social
@arosen380.bsky.social
@johnlin08.bsky.social
@lymphomadoc.bsky.social
@anirbanmaitra.bsky.social

Who am I missing? We've got x3️⃣ the chance to do good in our community. See how below.
👇👇👇

1 year ago 24 4 3 0

👋

1 year ago 1 0 0 0
ASCO Meetings

ASCO annual meeting 2025 abstract submitter open - closes Jan 28th.

To support global innovation in cancer research, payment waivers offered to 1st authors from low- & lower-middle-income countries (World Bank)!

Apply for a waiver when you submit an abstract

conferences.asco.org/am/abstract-...

1 year ago 36 22 2 5

Team #MedSky #OncSky
Please join me in welcoming Dr Julia Close, an oncologist and the ASCO Chief Education Officer, and a Florida 🐊! Please follow her and amplify her account so Oncology trainees can find her.

1 year ago 21 0 2 0
Post image

The @OncoAlert 🚨Newsletter Covering September Nov 14-21, 2024
REGISTER AT www.OncoAlert360.com OR https://buff.ly/48Xpgz0

✅ Goteborg 🇸🇪in #prostatecancer
✅Matching to Clinical trials w/GPT💻
✅PULSAR: ☢️Ultra-fractionated Stereotactive Adaptive RT in CNS
✅CHIPOR
✅EXENTORCH 🫁 #SCLC
✅TITAN

1 year ago 25 10 1 5
Preview
A real-world comparison of commercial use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma Key Points. Axi-cel and liso-cel had similar outcomes, though when accounting for differences in risk factors, axi-cel was associated with superior PFS.We

ashpublications.org/bloodadvance...

1 year ago 3 0 0 0
Post image

Important paper: Comparing axi-cel and liso-cel in patients receiving 3L+ therapy for relapsed large b-cell lymphoma. Outcomes similar to trials, but liso-cel takes longer and when matched, axi-cel improved PFS. @oncoalert.bsky.social
#lymsm #medsky #oncsky

1 year ago 19 4 1 0

Great idea!

1 year ago 1 0 0 0
Advertisement
Preview
Advocacy Summit on Capitol Hill Your voice matters. As oncologists, you are uniquely qualified to communicate with Congress about effective policies for the treatment of patients with cancer and the research that drives scientific b...

Sign up here: society.asco.org/get-involved...

1 year ago 2 1 1 0
Post image

Advocacy is another way we serve our patients. Rounding on the inpatient service this week, IV fluid shortages are a reminder that there is more work to do. Join us at the Advocacy Summit April 6-8, 2025. #ASCOAdvocacy #MedSky

1 year ago 7 2 1 0
Preview
a group of avengers are fighting each other in a scene from the movie avengers ALT: a group of avengers are fighting each other in a scene from the movie avengers

society.asco.org/get-involved...

1 year ago 0 0 0 0
Post image

Hey ASCO advocates, assemble! It’s time to sign up, block your calendar, and get ready to advocate for your patients. Link ⬇️ 4/6-8/2025 - Bonus: let’s follow each other. Tag your #ASCOAdvocacy friends in response below:

1 year ago 3 0 1 0
Post image

I’m sharing a post from X for those that aren’t on both:
The ASCO election is open and I’m honored to be on the ballot for the Board of Directors. Learn about all the amazing candidates and vote🗳️⬇️
ASCO.org/election

1 year ago 10 1 1 0


Looking for medical professionals to follow? Just created a third (non-exhaustive) starter pack 🩺🧪 medsky

Round 3
go.bsky.app/9WQtZh6

Round 1
go.bsky.app/Qg2TA9p

Round 2
go.bsky.app/9ziyYqt

Feel free to let me know others to add and they will be added to the third (until it maxes out at 150)

1 year ago 205 72 92 27